You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

allo-HSCTs transplant

Showing 1 - 25 of 6,746
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloid Leukemia, Acute Trial in France (Bone osteodensitometry)

Not yet recruiting
  • Myeloid Leukemia, Acute
  • Bone osteodensitometry
  • Amiens, France
  • +3 more
Dec 6, 2021

Immune Reconstitution After Allo-HSCT and Blinatumomab

Not yet recruiting
  • Leukemia, Lymphoid
  • (no location specified)
Oct 3, 2023

Auto/Allo Tandem Transplant for Relapsed B-NHL

Completed
  • Non Hodgkin Lymphoma
  • auto transplant followed by allo transplant
  • (no location specified)
Oct 24, 2022

Leukemia Trial (Prehabilitation)

Not yet recruiting
  • Leukemia
  • Prehabilitation
  • (no location specified)
Dec 5, 2022

Hematologic Malignancy, Stem Cell Transplant Complications Trial in Beijing (Beijing protocol)

Recruiting
  • Hematologic Malignancy
  • Stem Cell Transplant Complications
  • Beijing protocol
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Jun 19, 2023

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Peripheral Blood Stem Cell Transplant
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Mar 27, 2023

CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)

Not yet recruiting
  • CMV Infection
  • +2 more
  • Virus specific T cells
  • (no location specified)
Oct 4, 2023

CARPET Prognostic Model for Septic Shock After Allo-HSCT

Not yet recruiting
  • Stem Cell Transplant Complications
  • CARPET prognostic model
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Aug 31, 2023

Relapsed/Refractory Multiple Myeloma Trial in United States (genetic, biological, drug)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • ALLO-605
  • +3 more
  • Denver, Colorado
  • +3 more
Feb 9, 2022

Hematologic Malignancy Trial in Pavia, Rome, Turin (BPX-501 T cells, rimiducid)

Active, not recruiting
  • Hematologic Malignancy
  • Pavia, Italy
  • +2 more
Jul 10, 2022

MPS-IH (Hurler Syndrome) Trial in Worldwide (Experimental: OTL-203, Active Comparator: Allo-HSCT)

Not yet recruiting
  • MPS-IH (Hurler Syndrome)
  • Experimental: OTL-203
  • Active Comparator: Allo-HSCT
  • Oakland, California
  • +6 more
Nov 27, 2023

Resolving Inflammaging Allo HSCT Survivors in Personal Training

Completed
  • Allogeneic HCT Survivors
  • 10 Weeks of Strength Trailing
  • Group Nutrition Discussion: week 1, week 5 and week 10
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Mar 31, 2022

Hematologic Diseases Trial in Palo Alto (biological, device, drug)

Recruiting
  • Hematologic Diseases
  • Allogeneic Stem Cell Transplant
  • +2 more
  • Palo Alto, California
    Lucile Packard Children's Hospital
Mar 25, 2022

Allogeneic Stem Cell Transplantation in Elderly: 17-years

Completed
  • Allogeneic Stem Cell Transplantation in Elderly Patients
    • Brescia, Italy
      Chair of Hematology and Bone marrow Transplant Unit
    Jul 21, 2021

    Relapsed/Refractory Multiple Myeloma Trial in United States (genetic, biological, drug)

    Recruiting
    • Relapsed/Refractory Multiple Myeloma
    • ALLO-715
    • +4 more
    • Gilbert, Arizona
    • +11 more
    Feb 18, 2022

    Acute Myeloid Leukemia, Allogeneic Hematopoietic Cell Transplantation Trial in Minneapolis (Fecal Microbiota Transplant (FMT),

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Allogeneic Hematopoietic Cell Transplantation
    • Fecal Microbiota Transplant (FMT)
    • Placebo
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Feb 16, 2022

    Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)

    Terminated
    Has Results
    • Myelodysplastic Syndrome
    • +2 more
    • GVAX
    • +6 more
    • Boston, Massachusetts
    • +3 more
    Jun 30, 2022

    Acute GVHD (Gvhd) Grade, Hematopoietic Cell Transplantation, Fecal Microbiota Transplant Trial in Boston (Fecal Microbiota

    Recruiting
    • Acute Graft-Versus-Host Disease (Gvhd) Grade
    • +2 more
    • Fecal Microbiota Transplant
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 29, 2021

    Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma

    Recruiting
    • Multiple Myeloma
    • Stem Cell Transplant
      • Firenze, Italy
      • +1 more
      Aug 19, 2021

      Chronic Graft-versus-host-disease Trial in Lebanon (Ibrutinib, Rituximab)

      Terminated
      • Chronic Graft-versus-host-disease
      • Lebanon, New Hampshire
        Dartmouth-Hitchcock Medical Center
      Sep 27, 2021

      Acute Myeloid Leukemia (AML) Trial in Charlotte (Allogeneic HCT, Consolidation chemo)

      Terminated
      Has Results
      • Acute Myeloid Leukemia (AML)
      • Allogeneic HCT
      • Consolidation chemotherapy
      • Charlotte, North Carolina
        Levine Cancer Institute
      Apr 19, 2022

      Leukemia, Erythroblastic, Acute, MDS Trial in New York (5-Azacytidine, Fludarabine, Melphalan)

      Completed
      Has Results
      • Leukemia, Erythroblastic, Acute
      • Myelodysplastic Syndromes
      • New York, New York
        Weill Cornell Medical College
      Aug 25, 2021

      Acute Leukemia, Relapse, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (Sorafenib)

      Recruiting
      • Acute Leukemia
      • +2 more
      • Guangzhou, Guangdong, China
        Department of Hematology,Nanfang Hospital, Southern Medical Univ
      Oct 30, 2021

      Transplantation, Hematopoietic Stem Cell Trial in Lyon (Biological samples (blood and oral fluid))

      Not yet recruiting
      • Transplantation, Hematopoietic Stem Cell
      • Biological samples (blood and oral fluid)
      • Lyon, France
        Hôpital de la Croix Rousse - service des maladies infectieuses e
      Jul 7, 2023

      GVHD, Acute Trial in Denmark, Norway, Sweden (Decidua Stroma Cells (DSC), Best available Treatment (BAT))

      Recruiting
      • GVHD, Acute
      • Decidua Stroma Cells (DSC)
      • Best available Treatment (BAT)
      • Copenhagen, Denmark
      • +5 more
      Sep 30, 2021